PharmEasy may soon close $100-mn funding round backed by existing investors

The new round is expected to see participation from Avendus Capital, Eight Roads Ventures India, F-Prime Capital, among others

Mumbai-based online pharmacy and healthcare start-up PharmEasy may soon close a $100 million Series D funding from existing investors. The proceeds will be used to support customer acquisition and technology enhancement. The company is expecting a break-even in 24-30 months.

The new round is expected to see participation from Avendus Capital, Eight Roads Ventures India, F-Prime Capital, Nandan Nilekani and Sanjeev Aggarwal's Fundamentum Partnership and Think Investments, said sources privy to the talks. 

PharmEasy management refused to comment on the fund raising plans.

Without confirming any fund raising plan, Dharmil Sheth, co-founder of PharmEasy said that any funding raised in